Clinical implications of next‐generation sequencing‐based panel tests for malignant ovarian tumors

Precision medicine based on cancer genomics is being applied in clinical practice. However, patients do not always derive benefits from genomic testing. Here, we performed targeted amplicon exome sequencing‐based panel tests, including 160 cancer‐related genes (PleSSision‐160), on 88 malignant ovari...

Descripción completa

Detalles Bibliográficos
Autores principales: Saotome, Keiko, Chiyoda, Tatsuyuki, Aimono, Eriko, Nakamura, Kohei, Tanishima, Shigeki, Nohara, Sachio, Okada, Chihiro, Hayashi, Hideyuki, Kuroda, Yuka, Nomura, Hiroyuki, Susumu, Nobuyuki, Iwata, Takashi, Yamagami, Wataru, Kataoka, Fumio, Nishihara, Hiroshi, Aoki, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571820/
https://www.ncbi.nlm.nih.gov/pubmed/32813918
http://dx.doi.org/10.1002/cam4.3383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571820/
https://www.ncbi.nlm.nih.gov/pubmed/32813918
http://dx.doi.org/10.1002/cam4.3383

Ejemplares similares